| 标题 |
First-in-human, phase I study of clesitamig, a DLL3-targeted CD3×4-1BB trispecific T-cell engager in patients with advanced small-cell lung cancer and other neuroendocrine carcinomas |
| 网址 | |
| DOI |
10.1136/jitc-2026-016578
doi
|
| 其它 |
期刊:Journal for ImmunoTherapy of Cancer 作者:Tatsuya Yoshida; Stephen Fowler; Izolda Franjkovic; Nino Gochitashvili; Charlotte Lane; et al 出版日期:2026-11-01 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)